- Home
- PLX vs ALTO Comparison
PLX vs ALTO Comparison
Compare PLX & ALTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLX | ALTO |
|---|---|---|
| Founded | 1993 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 230.0M | 194.1M |
| IPO Year | 1996 | 2005 |
Fundamental Metrics
Financial Performance| Metric | PLX | ALTO |
|---|---|---|
| Price | $2.87 | $4.29 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | 1.1M | ★ 2.5M |
| Earning Date | 01-01-0001 | 06-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 119.51 |
| EPS | N/A | ★ 0.16 |
| Revenue | $53,399,000.00 | ★ $917,927,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $23.86 | N/A |
| P/E Ratio | ★ N/A | $26.94 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.34 | $0.76 |
| 52 Week High | $3.19 | $4.89 |
Technical Indicators
Market Signals| Indicator | PLX | ALTO |
|---|---|---|
| Relative Strength Index (RSI) | 53.93 | 68.00 |
| Support Level | $2.59 | $0.95 |
| Resistance Level | $3.03 | N/A |
| Average True Range (ATR) | 0.13 | 0.32 |
| MACD | -0.04 | 0.17 |
| Stochastic Oscillator | 56.31 | 77.08 |
Price Performance
Historical ComparisonAbout PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
About ALTO Alto Ingredients Inc.
Alto Ingredients Inc is a producer of specialty alcohols and essential ingredients. The company serves five markets: Health, Home and Beauty, Food and Beverage, Essential Ingredients, and Renewable Fuels. Its customers include food and beverage companies and consumer products manufacturers and distributors. The company operates under four segments: Marketing and distribution, Pekin Campus production, Western production, and Corporate.